Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion
International Journal of Stroke, Volume 12, No. 1, Year 2017
Notification
URL copied to clipboard!
Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed by rt-PA and/or thrombectomy in patients with ischemic stroke pre-treated with dabigatran. The use of idarucizumab followed by rt-PA is covered by the label of both drugs.